Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine

M Kasravi, A Ahmadi, A Babajani… - Biomaterials …, 2023 - spj.science.org
Tissue-engineered decellularized extracellular matrix (ECM) scaffolds hold great potential to
address the donor shortage as well as immunologic rejection attributed to cells in …

Crosslinking strategies of decellularized extracellular matrix in tissue regeneration

S Qiao, T Peijie, J Nan - Journal of Biomedical Materials …, 2024 - Wiley Online Library
By removing the immunogenic cellular components through various decellularization
methods, decellularized extracellular matrix (dECM) is considered a promising material in …

Recent Advances in the Modification and Improvement of Bioprosthetic Heart Valves

Q Tong, J Cai, Z Wang, Y Sun, X Liang, Q Xu… - Small, 2024 - Wiley Online Library
Valvular heart disease (VHD) has become a burden and a growing public health problem in
humans, causing significant morbidity and mortality worldwide. An increasing number of …

[HTML][HTML] Application of homograft valved conduit in cardiac surgery

Y Huyan, Y Chang, J Song - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Valved conduits often correct the blood flow of congenital heart disease by connecting the
right ventricle to the pulmonary artery (RV-PA). The homograft valved conduit was invented …

[HTML][HTML] Graft rejection in paediatric congenital heart disease

AG Harris, D Iacobazzi, M Caputo… - Translational …, 2023 - ncbi.nlm.nih.gov
Congenital heart disease (CHD) affects around 1.35 million neonates worldwide per annum,
and surgical repair is necessary in approximately 25% of cases. Xenografts, usually of …